BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 18760321)

  • 21. Reduced platelet monoamine oxidase type B activity and lymphocyte muscarinic receptor binding in unmedicated children with attention deficit hyperactivity disorder.
    Coccini T; Crevani A; Rossi G; Assandri F; Balottin U; Nardo RD; Manzo L
    Biomarkers; 2009 Nov; 14(7):513-22. PubMed ID: 19863190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy.
    Kobayashi K; Shimizu E; Hashimoto K; Mitsumori M; Koike K; Okamura N; Koizumi H; Ohgake S; Matsuzawa D; Zhang L; Nakazato M; Iyo M
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):658-63. PubMed ID: 15905010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex-specific association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and plasma BDNF with attention-deficit/hyperactivity disorder in a drug-naïve Han Chinese sample.
    Li H; Liu L; Tang Y; Ji N; Yang L; Qian Q; Wang Y
    Psychiatry Res; 2014 Jul; 217(3):191-7. PubMed ID: 24713358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood levels of brain-derived neurotrophic factor correlate with several psychopathological symptoms in anorexia nervosa patients.
    Mercader JM; Fernández-Aranda F; Gratacòs M; Ribasés M; Badía A; Villarejo C; Solano R; González JR; Vallejo J; Estivill X
    Neuropsychobiology; 2007; 56(4):185-90. PubMed ID: 18337636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low blood levels of lead and mercury and symptoms of attention deficit hyperactivity in children: a report of the children's health and environment research (CHEER).
    Ha M; Kwon HJ; Lim MH; Jee YK; Hong YC; Leem JH; Sakong J; Bae JM; Hong SJ; Roh YM; Jo SJ
    Neurotoxicology; 2009 Jan; 30(1):31-6. PubMed ID: 19100765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest-posttest study.
    Akay AP; Resmi H; Güney SA; Erkuran HÖ; Özyurt G; Sargin E; Topuzoglu A; Tufan AE
    Eur Child Adolesc Psychiatry; 2018 Jan; 27(1):127-135. PubMed ID: 28710695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attention-deficit hyperactivity disorder and blood mercury level: a case-control study in Chinese children.
    Cheuk DK; Wong V
    Neuropediatrics; 2006 Aug; 37(4):234-40. PubMed ID: 17177150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of brain-derived neurotrophic factor and substance P.
    Hon KL; Lam MC; Wong KY; Leung TF; Ng PC
    Br J Dermatol; 2007 Nov; 157(5):922-5. PubMed ID: 17725670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is decreased blood plasma concentration of the complement C4B protein associated with attention-deficit hyperactivity disorder?
    Warren RP; Odell JD; Warren WL; Burger RA; Maciulis A; Torres AR
    J Am Acad Child Adolesc Psychiatry; 1995 Aug; 34(8):1009-14. PubMed ID: 7665439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential effects of zinc on information processing in boys with attention deficit hyperactivity disorder.
    Yorbik O; Ozdag MF; Olgun A; Senol MG; Bek S; Akman S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):662-7. PubMed ID: 18083281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain-derived neurotrophic factor (BDNF) plasma levels in drug-naïve OCD patients are lower than those in healthy people, but are not lower than those in drug-treated OCD patients.
    Wang Y; Mathews CA; Li Y; Lin Z; Xiao Z
    J Affect Disord; 2011 Sep; 133(1-2):305-10. PubMed ID: 21616543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation.
    Kim TS; Kim DJ; Lee H; Kim YK
    Neurosci Lett; 2007 Aug; 423(1):53-7. PubMed ID: 17662528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The potential role of childhood ADHD in the development of heroin dependence at a young age].
    Szilágyi A; Barta C; Boór K; Székely A; Demetrovics Z; Csorba J; Kalász H; Sasvári-Székely M
    Neuropsychopharmacol Hung; 2007 Jun; 9(2):69-75. PubMed ID: 17970529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism.
    Hashimoto K; Iwata Y; Nakamura K; Tsujii M; Tsuchiya KJ; Sekine Y; Suzuki K; Minabe Y; Takei N; Iyo M; Mori N
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1529-31. PubMed ID: 16876305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased plasma brain-derived neurotrophic factor levels in patients with alcohol dependence.
    Joe KH; Kim YK; Kim TS; Roh SW; Choi SW; Kim YB; Lee HJ; Kim DJ
    Alcohol Clin Exp Res; 2007 Nov; 31(11):1833-8. PubMed ID: 17850220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD).
    Scassellati C; Zanardini R; Tiberti A; Pezzani M; Valenti V; Effedri P; Filippini E; Conte S; Ottolini A; Gennarelli M; Bocchio-Chiavetto L
    Eur Child Adolesc Psychiatry; 2014 Mar; 23(3):173-7. PubMed ID: 23812866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased plasma levels of brain-derived neurotrophic factor in patients with long-term bipolar disorder.
    Barbosa IG; Huguet RB; Mendonça VA; Neves FS; Reis HJ; Bauer ME; Janka Z; Palotás A; Teixeira AL
    Neurosci Lett; 2010 May; 475(2):95-8. PubMed ID: 20350583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low plasma BDNF is associated with suicidal behavior in major depression.
    Kim YK; Lee HP; Won SD; Park EY; Lee HY; Lee BH; Lee SW; Yoon D; Han C; Kim DJ; Choi SH
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):78-85. PubMed ID: 16904252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral brain-derived neurotrophic factor in attention-deficit/hyperactivity disorder: A comprehensive systematic review and meta-analysis.
    Zhang J; Luo W; Li Q; Xu R; Wang Q; Huang Q
    J Affect Disord; 2018 Feb; 227():298-304. PubMed ID: 29132072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia.
    Reis HJ; Nicolato R; Barbosa IG; Teixeira do Prado PH; Romano-Silva MA; Teixeira AL
    Neurosci Lett; 2008 Jul; 439(2):157-9. PubMed ID: 18514407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.